TAINAN, Taiwan — A Memorandum of Understanding (MOU) was signed between College of Medicine at National Cheng Kung University (NCKU), Tainan, Taiwan, and Waterloo Institute of Nanotechnology (WIN) at University of Waterloo, Canada, on July 21st in VIP Room, NCKU College of Medicine.
“The corporation between Harvard University and Massachusetts Institute of Technology (MIT), United States, is the best example. As Harvard University provides medical knowledge and MIT provides engineering technique, both universities have together created mutual resplendence and win-win situation.”
Executive Director Arthur J. Carty of Waterloo Institute for Nanotechnology, University of Waterloo, has signed the document with Vice Dean for Administration Jiun-Jong Wu of NCKU College of Medicine and discussed the details of future cooperation with NCKU Senior Executive Vice-President Da-Hsuan Feng, Chair Dar-Bin Shieh of NCKU Institute of Oral Medicine and Director Jang-Yang Chang of National Institute of Cancer Research at National Health Research Institutes (NHRI), Taiwan.
NCKU Senior Executive Vice-President Da-Hsuan Feng mentioned, “The Memorandum of Understanding signed between University of Waterloo and National Cheng Kung University is particularly unique because it involves Faculty of Engineering and College of Medicine.”
Prof. Frank Gu of Waterloo Institute of Nanotechnology also revealed, “The corporation between Harvard University and Massachusetts Institute of Technology (MIT), United States, is the best example. As Harvard University provides medical knowledge and MIT provides engineering technique, both universities have together created mutual resplendence and win-win situation.”
Chair Dar-Bin Shieh of NCKU Medical College of Oral Medicine expressed, “The main purpose of signing the MOU is to promote mutual collaboration in the fields of nanotechnology, energy and medicine. Canada and National Science Council, Taiwan, will both support the collaboration between Canada and Taiwan, including faculty and students exchange and research and development projects. I believe both institutes will complement and benefit from each other in the future technological exchange and clinical trials.”
The two institutes have agreed to join force to accelerate research innovations, foster interdisciplinary synergies in nanotechnology and medicine, organize a workshop which will be convened in University of Waterloo later this year or early next year and bring together researchers from Taiwan and Waterloo Institute for Nanotechnology with common interests to discuss possible collaborations, maintain frequent communications to ensure that momentum and commitment to the joint initiative are sustained, and initiate collaborative projects and research exchange.
University of Waterloo, established in 1957, is situated in the city of Waterloo, Ontario, Canada, covering an area of 400 hectares and having approximately 26,000 students and 12,000 co-op students. It is praised to be the Massachusetts Institute of Technology in Canada. The university has ranked third overall in the comprehensive category of 2009 Maclean magazine.
Dr. Arthur J. Carty received his doctoral degree of Inorganic Chemistry in University of Nottingham, England, in 1965. He was the Chairman of Department of Chemistry at University of Waterloo from 1983 to 1989, the Dean of Research at University of Waterloo from 1989 to 1994, President of National Research Council of Canada from 1994 to 2004, and National Science Advisor to the Prime Minister and to the Government of Canada from 2004 to 2008. Dr. Carty is currently the Executive Director of Waterloo Institute for Nanotechnology (WIN) and Special Advisor to the President on International Science and Technology.